Response to Letter to the Editor: "p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer". [electronic resource]
- The Journal of clinical endocrinology and metabolism 09 2018
- 3518-3519 p. digital